iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s share price shot up 0.3% on Monday . The company traded as high as $36.76 and last traded at $36.70. 12,738 shares were traded during trading, an increase of 461% from the average session volume of 2,269 shares. The stock had previously closed at $36.60.
iShares Neuroscience and Healthcare ETF Stock Performance
The firm’s 50 day moving average is $36.91 and its 200-day moving average is $34.44. The firm has a market cap of $5.70 million, a price-to-earnings ratio of 15.61 and a beta of 0.75.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Featured Articles
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
